tiprankstipranks
Zentalis downgraded to Hold from Buy at Jefferies
PremiumThe FlyZentalis downgraded to Hold from Buy at Jefferies
1M ago
Zentalis downgraded to Equal Weight from Overweight at Morgan Stanley
PremiumThe Fly
Zentalis downgraded to Equal Weight from Overweight at Morgan Stanley
1M ago
Zentalis price target lowered to $20 from $40 at H.C. Wainwright
PremiumThe Fly
Zentalis price target lowered to $20 from $40 at H.C. Wainwright
1M ago
Zentalis downgraded to Equal Weight from Overweight at Wells Fargo
PremiumThe FlyZentalis downgraded to Equal Weight from Overweight at Wells Fargo
1M ago
Zentalis price target lowered to $25 from $50 at Oppenheimer
PremiumThe Fly
Zentalis price target lowered to $25 from $50 at Oppenheimer
1M ago
Zentalis Pharmaceuticals Provides Update on Azenosertib Clinical Development Program
PremiumPress Releases
Zentalis Pharmaceuticals Provides Update on Azenosertib Clinical Development Program
1M ago
Zentalis Pharmaceuticals Appoints Luke Walker to Board
PremiumCompany AnnouncementsZentalis Pharmaceuticals Appoints Luke Walker to Board
2M ago
Zentalis appoints Luke Walker to board of directors
PremiumThe Fly
Zentalis appoints Luke Walker to board of directors
2M ago
Zentalis Pharmaceuticals Announces Appointment of Accomplished Oncology Drug Developer Luke Walker, M.D., to Board of Directors
PremiumPress Releases
Zentalis Pharmaceuticals Announces Appointment of Accomplished Oncology Drug Developer Luke Walker, M.D., to Board of Directors
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100